Curai Health delivers virtual primary and urgent care beyond what is humanly possible. Curai provides 24/7 service across all 50 states as a white-labeled extension of our health system clients. Partnering with Curai allows health systems to serve a significantly increased volume of patients with far less capital investment and operating expenses than existing models. This is made possible with a technology approach that combines the efficiencies of artificial intelligence with the expertise of clinicians; the Curai approach has mitigated some of the current outstanding limitations and concerns regarding large language models and ChatGPT. 

Curai Health is a chat-first virtual clinic on a mission to democratize access to high-quality, affordable care by leveraging thoughtful AI deployments. 

As the pioneer in deploying machine learning into clinical workflows, Curai Health enables its dedicated, specially trained clinicians to deliver primary care to more people at a fraction of the cost. Easy-to-use and convenient, Curai Health partners with insurers and health systems to keep patients engaged in their care over time, improving health outcomes and reducing costs. 

Backed by leading investors including Morningside Ventures, General Catalyst, and Khosla Ventures, Curai Health has been thoughtfully combining the expertise of clinicians with the efficiencies of artificial intelligence since its founding in 2017. 

VPExam provides optimal longitudinal Heart Failure management with continuity of care from home the clinic to the ER to the ICU and back.

The mission is to decentralize access to Cardiovascular Care. Our platform facilitates a highly effective and efficient transitional care program for cardiac patients, initially focusing on heart failure. The VPExam platform assists in the early detection of cardiac abnormalities and decompensation by proactively managing patient care: the physician improves patient quality of care, reducing re-hospitalizations and delivering more efficient, cost-effective care to the patient. The VPExam platform overcomes the barriers of traditional telemedicine, allowing comprehensive physical examinations utilizing Augmented Reality (AR) guidance.

The virtual care landscape is very broad, with companies focusing on different approaches to care, technology, specialty care, devices and therapeutics. We believe our primary differentiators are: 

• Machine Learning and Automation: Curai has purposefully built state-of-the-art AI algorithms and automation into our proprietary technology infrastructure, operating system, and care model. We are one of the only healthcare companies leveraging the latest breakthroughs in natural language processing (NLP), advanced large language models (LLMs) including GPT-4 that gives our system the ability to learn and improve as we expand the scope of our offering. Furthermore, our team of world-renowned engineers and scientists is deeply committed to transparency and publishing our work and has 17 publications in top-tier, peer-reviewed academic journals.
• Operational Efficiency of Care Team- Using our scalable, AI-enabled care model and operating system, we can ensure seamless continuity of care across care team members and continuous learning from our own highly structured data on a variety of tasks including triage, patient history-taking, automated diagnosis, medication recommendation/management, automated note summarization, and conversational AI.
• Cost- Curai Health offers high-quality care and lower costs on a per-visit basis today, and an AI/ML approach that allows for continued, long-term cost advantages over time.

• We partner with Cardiologists to improve the lives of their patients by overcoming barriers of traditional telemedicine using optimized VPExam virtual care workflows.

• VPExam is the first cardiology focused value-based care company to use technology and continuous care management to deliver peer reviewed publications documenting improved health with reduced readmissions and mortality of cardiovascular patients while significantly reducing cost of care.

o Enables better care for sicker and more complex HF patients.

o Cost effective and portable care to reach high-risk underserved populations in nursing facilities, hospitals, offices, and into the home.

o Customized to each physician with actionable and timely results.

• VPExam Virtual Care for Heart Failure Optimizing Transitions (VPExam QI)

o Revealed 84% moderate clinical modification in care, 40.1% reduction in 30-day rehospitalization, 56.3% reduction in 30-day mortality, 100% compliance with

follow up, and 0% technical errors.

• Growing industry recognition for multiple publications and awards including the Heart Rhythm Society (HRS) Breakthrough Innovation in Cardiovascular Digital Health and Digital Health Hub Foundation 2023 Best in Class Next Generation Telemedicine awards.